Gian Life Care Peer Comparison

BSE: 542918

₹4.68

₹-0.19 (-3.90%)

As on 28-Aug-2026IST

Market cap

₹5 Cr

Revenue (TTM)

₹4 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Market cap (₹ Cr)	5	39,538	32,407	32,332	14,953
Revenue (₹ Cr)	4	4,683	2,891	4,213	857
Net Profit (₹ Cr)	-0.95	552.34	546.30	190.80	187.49
Net Margin (%)	-24.68	11.55	18.23	4.49	21.32
RoE (%)	-5.01	14.93	23.03	9.45	20.58
Price to Earnings	--	71.09	59.80	158.26	79.76
Price-To-Book	0.26	9.62	12.40	8.54	14.85

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Operating Revenue	3.76	3,692.35	2,461.40	3,035.10	681.39
Total Income	3.85	3,797.15	2,554.83	3,067.00	699.71
Total Expenditure	3.76	2,831.90	1,765.80	2,242.10	408.17
EBITDA	0.00	860.44	695.60	793.00	273.22
Depreciation	0.45	193.75	141.92	177.20	70.60
EBIT	-0.45	666.69	553.67	615.80	202.62
Interest	0.43	74.35	22.31	100.40	26.74
Other Income	0.09	104.81	93.43	31.90	18.32
Exceptional Items	0.00	-49.90	--	10.80	-1.03
Profit before Tax	-0.78	647.26	624.80	558.10	193.16
Provision for Tax	-0.02	165.94	132.55	143.30	49.37
Profit after Tax	-0.76	481.32	492.25	414.80	143.79

Liabilities (₹ Cr)

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Shareholder's Funds	19.35	3,386.41	2,172.72	2,137.80	799.14
Minority Interest	0.00	1.10	33.76	281.00	2.72
Non-Current Liabilities	3.23	726.88	21.34	2,421.10	311.86
Current Liabilities	11.20	618.82	402.35	836.20	162.61
Total Liabilities	--	4,766.23	2,713.41	5,689.20	1,273.62

Assets (₹ Cr)

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Non-Current Assets	13.88	3,200.08	1,266.66	4,978.80	966.41
Current Assets	19.45	1,533.12	1,363.51	697.30	307.21
Total Assets	--	4,766.23	2,713.41	5,689.20	1,273.62
Total Debt*	--	327.88	0.00	1,910.90	0.00
Net Current Assets	8.25	914.31	961.16	-138.90	144.59
Contingent Liabilities	--	88.77	10.59	83.80	0.13

Cashflow (₹ Cr)

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Cash From Operating Activities	--	623.76	568.89	581.80	224.47
Cash Flow from Investing Activities	--	-720.94	-303.16	-1,116.20	-181.88
Cash from Financing Activities	--	-97.23	-334.03	543.10	-52.05
Net Cash Inflow / Outflow	--	-194.41	-68.31	8.70	-9.45

Ratios

Profitability Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
ROCE (%)	--	20.50	31.53	19.02	30.20
ROE (%)	-3.90	15.31	25.15	20.92	19.99
ROA (%)	-2.26	10.72	19.53	8.74	12.76
EBIT Margin (%)	-11.83	26.14	32.06	27.18	42.79
Net Margin (%)	-19.77	12.68	19.27	13.52	20.55
Cash Profit Margin (%)	0.00	18.28	25.76	19.51	31.46

Growth Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Revenue Growth (%)	-62.82	12.74	10.54	21.49	24.39
EBIT Growth (%)	-112.34	9.24	16.31	24.83	20.61
Net Profit Growth (%)	-126.91	0.68	35.87	23.49	20.19
EPS Growth (%)	-126.91	0.65	35.99	24.03	20.67
Book Value Growth (%)	--	16.71	17.68	16.93	19.36

Valuation Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Price / Earnings	-6.35	66.85	21.26	66.51	71.86
Price / Book Value	0.25	9.50	9.79	11.96	13.20
Dividend Yield (%)	0.00	0.04	0.97	0.00	0.20
EV/EBITDA	1,241.54	32.52	25.19	33.22	35.28
Market Cap (₹ Cr)	--	32,181.74	20,714.85	25,571.93	10,333.01

Solvency Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Debt to Equity	0.12	0.10	0.00	0.89	0.00
Short term debt to equity ratio	--	--	--	0.06	--
Current Ratio	1.74	2.48	3.39	0.83	1.89
Quick Ratio	1.68	2.37	3.30	0.76	1.86
Interest Coverage	-0.83	9.71	29.01	6.56	8.22

Operating Efficiency Ratios

	Gian Life Care	Global Health	Dr. Lal Pathlabs	Krishna Institute	Vijaya Diagno
Debtors to sales (%)	162.24	7.90	3.58	13.03	2.17
Asset Turnover	0.11	0.82	0.98	0.64	0.60
Receivable days	--	25.07	12.27	41.48	8.30
Inventory Days	--	6.62	5.45	6.82	2.71
Payable days	--	79.17	134.04	135.60	142.28
Cash Conversion Cycle	--	-47.48	-116.32	-87.31	-131.27

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.